文献速递其他结缔组织病血管炎

抗中性粒细胞胞外诱捕网抗体与抗磷脂综合征中NET降解受损

Anti-Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome.
PubMed 文献 · Arthritis Rheumatol · 2020-10-16

本研究在76例原发性抗磷脂综合征(APS)患者中检测抗中性粒细胞胞外诱捕网(NET)抗体,发现其IgG和IgM水平显著高于健康对照,且与传统抗磷脂抗体无关。抗NET抗体(尤其IgG)损害血清降解NET的能力,抗NET IgM与补体C4负相关,抗NET抗体与复发性静脉血栓相关。

要点

  • 原发性APS患者抗NET IgG和IgM水平显著高于健康对照。
  • 抗NET抗体(尤其IgG)损害NET降解,抗NET IgM与补体C4负相关。
  • 抗NET抗体与复发性静脉血栓相关(OR 4.3,P=0.002)。

核心结论

  • 原发性APS患者存在高水平的抗NET抗体,可能损害NET清除并激活补体级联,有助于风险分层。

研究设计与样本

  • 测量76例原发性APS、23例无aPL的SLE、11例无aPL的特发性静脉血栓患者及44例健康对照的总体抗NET活性,并评估APS血清降解NET的能力。

主要发现

  • 原发性APS患者抗NET IgG平均OD 0.55±0.34 vs 健康对照0.33±0.17,IgM 0.76±0.51 vs 0.26±0.23。
  • 抗NET活性与传统aPL水平不相关,且相对稳定。
  • 抗NET抗体(尤其IgG)损害血清降解NET能力(r=0.4,P=0.003)。
  • 抗NET IgM与补体C4负相关(r=0.4,P=0.019)。
  • 抗NET抗体与复发性静脉血栓相关(OR 4.3,P=0.002)。

临床怎么用

  • 抗NET抗体可能作为原发性APS风险分层的新型生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The release of neutrophil extracellular traps (NETs) by hyperactive neutrophils has recently been recognized to play an important role in antiphospholipid syndrome (APS). This study was undertaken to evaluate autoantibodies targeting NETs in patients with primary APS, and to determine their potential functions and clinical associations. METHODS: We measured global anti-NET activity in 76 patients with primary APS, 23 patients with systemic lupus erythematosus without antiphospholipid antibodies (aPL), 11 patients with a history of unprovoked venous thrombosis without aPL, and 44 healthy controls. The ability of APS sera to degrade NETs was also assessed. RESULTS: We found markedly elevated levels of anti-NET IgG and IgM in patients with primary APS compared with healthy controls (for IgG, mean ± SD optical density 0.55 ± 0.34 versus 0.33 ± 0.17; for IgM, mean ± SD optical density 0.76 ± 0.51 versus 0.26 ± 0.23). This anti-NET activity did not correlate with levels of traditional aPL and was relatively stable over time. Mechanistically, anti-NET antibodies (especially of the IgG isotype) impaired the ability of patient sera to degrade NETs (r = 0.4, P = 0.003). Levels of anti-NET IgM inversely correlated with complement C4 (r = 0.4, P = 0.019). Clinically, anti-NET antibodies associated with certain APS clinical manifestations, and in particular recurrent venous thrombosis (odds ratio 4.3; P = 0.002). Interestingly, anti-NET antibody levels also appeared to be associated with unprovoked venous thrombosis in the general population (for IgM, mean ± SD optical density 0.67 ± 0.34 versus 0.26 ± 0.23). CONCLUSION: Our data indicate high levels of anti-NET antibodies in patients with primary APS, which may impair NET clearance and activate the complement cascade. These findings may ultimately enable more effective risk stratification.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Zuo Y, Yalavarthi S, Gockman K, et al. Anti-Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome. Arthritis Rheumatol. 2020. PMID: 32729667. doi:10.1002/art.41460

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。